Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
NGS-based RNA-sequencing market report explains the definition, types, applications, major countries, and major players of the NGS-based RNA-sequencing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Eurofins Genomics Germany GmbH
Oxford Nanopore Technologies
QIAGEN
Hamilton Company
BGI
Zymo Research
Illumina, Inc
Thermo Fisher Scientific Inc
Psomagen, Inc
PerkinElmer Inc
Takara Bio Inc
Tecan Genomics, Inc
Agilent Technologies, Inc
By Type:
Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing
Nanopore Sequencing
By End-User:
Research & Academia
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global NGS-based RNA-sequencing Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 NGS-based RNA-sequencing Outlook to 2028- Original Forecasts
-
2.2 NGS-based RNA-sequencing Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term NGS-based RNA-sequencing Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global NGS-based RNA-sequencing Market- Recent Developments
-
6.1 NGS-based RNA-sequencing Market News and Developments
-
6.2 NGS-based RNA-sequencing Market Deals Landscape
7 NGS-based RNA-sequencing Raw Materials and Cost Structure Analysis
-
7.1 NGS-based RNA-sequencing Key Raw Materials
-
7.2 NGS-based RNA-sequencing Price Trend of Key Raw Materials
-
7.3 NGS-based RNA-sequencing Key Suppliers of Raw Materials
-
7.4 NGS-based RNA-sequencing Market Concentration Rate of Raw Materials
-
7.5 NGS-based RNA-sequencing Cost Structure Analysis
-
7.5.1 NGS-based RNA-sequencing Raw Materials Analysis
-
7.5.2 NGS-based RNA-sequencing Labor Cost Analysis
-
7.5.3 NGS-based RNA-sequencing Manufacturing Expenses Analysis
8 Global NGS-based RNA-sequencing Import and Export Analysis (Top 10 Countries)
-
8.1 Global NGS-based RNA-sequencing Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global NGS-based RNA-sequencing Export by Region (Top 10 Countries) (2017-2028)
9 Global NGS-based RNA-sequencing Market Outlook by Types and Applications to 2022
-
9.1 Global NGS-based RNA-sequencing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sequencing by Synthesis Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ion Semiconductor Sequencing Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Single-molecule Real-time Sequencing Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Nanopore Sequencing Consumption and Growth Rate (2017-2022)
-
9.2 Global NGS-based RNA-sequencing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research & Academia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise NGS-based RNA-sequencing Market Analysis and Outlook till 2022
-
10.1 Global NGS-based RNA-sequencing Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States NGS-based RNA-sequencing Consumption (2017-2022)
-
10.2.2 Canada NGS-based RNA-sequencing Consumption (2017-2022)
-
10.2.3 Mexico NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.2 UK NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.3 Spain NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.4 Belgium NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.5 France NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.6 Italy NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.7 Denmark NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.8 Finland NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.9 Norway NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.10 Sweden NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.11 Poland NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.12 Russia NGS-based RNA-sequencing Consumption (2017-2022)
-
10.3.13 Turkey NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.2 Japan NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.3 India NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.4 South Korea NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.5 Pakistan NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.6 Bangladesh NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.7 Indonesia NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.8 Thailand NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.9 Singapore NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.10 Malaysia NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.11 Philippines NGS-based RNA-sequencing Consumption (2017-2022)
-
10.4.12 Vietnam NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.2 Colombia NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.3 Chile NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.4 Argentina NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.5 Venezuela NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.6 Peru NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.7 Puerto Rico NGS-based RNA-sequencing Consumption (2017-2022)
-
10.5.8 Ecuador NGS-based RNA-sequencing Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain NGS-based RNA-sequencing Consumption (2017-2022)
-
10.6.2 Kuwait NGS-based RNA-sequencing Consumption (2017-2022)
-
10.6.3 Oman NGS-based RNA-sequencing Consumption (2017-2022)
-
10.6.4 Qatar NGS-based RNA-sequencing Consumption (2017-2022)
-
10.6.5 Saudi Arabia NGS-based RNA-sequencing Consumption (2017-2022)
-
10.6.6 United Arab Emirates NGS-based RNA-sequencing Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria NGS-based RNA-sequencing Consumption (2017-2022)
-
10.7.2 South Africa NGS-based RNA-sequencing Consumption (2017-2022)
-
10.7.3 Egypt NGS-based RNA-sequencing Consumption (2017-2022)
-
10.7.4 Algeria NGS-based RNA-sequencing Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia NGS-based RNA-sequencing Consumption (2017-2022)
-
10.8.2 New Zealand NGS-based RNA-sequencing Consumption (2017-2022)
11 Global NGS-based RNA-sequencing Competitive Analysis
-
11.1 Eurofins Genomics Germany GmbH
-
11.1.1 Eurofins Genomics Germany GmbH Company Details
-
11.1.2 Eurofins Genomics Germany GmbH NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Eurofins Genomics Germany GmbH NGS-based RNA-sequencing Main Business and Markets Served
-
11.1.4 Eurofins Genomics Germany GmbH NGS-based RNA-sequencing Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Oxford Nanopore Technologies
-
11.2.1 Oxford Nanopore Technologies Company Details
-
11.2.2 Oxford Nanopore Technologies NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Oxford Nanopore Technologies NGS-based RNA-sequencing Main Business and Markets Served
-
11.2.4 Oxford Nanopore Technologies NGS-based RNA-sequencing Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 QIAGEN
-
11.3.1 QIAGEN Company Details
-
11.3.2 QIAGEN NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 QIAGEN NGS-based RNA-sequencing Main Business and Markets Served
-
11.3.4 QIAGEN NGS-based RNA-sequencing Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Hamilton Company
-
11.4.1 Hamilton Company Company Details
-
11.4.2 Hamilton Company NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Hamilton Company NGS-based RNA-sequencing Main Business and Markets Served
-
11.4.4 Hamilton Company NGS-based RNA-sequencing Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 BGI
-
11.5.1 BGI Company Details
-
11.5.2 BGI NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 BGI NGS-based RNA-sequencing Main Business and Markets Served
-
11.5.4 BGI NGS-based RNA-sequencing Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Zymo Research
-
11.6.1 Zymo Research Company Details
-
11.6.2 Zymo Research NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Zymo Research NGS-based RNA-sequencing Main Business and Markets Served
-
11.6.4 Zymo Research NGS-based RNA-sequencing Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Illumina, Inc
-
11.7.1 Illumina, Inc Company Details
-
11.7.2 Illumina, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Illumina, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.7.4 Illumina, Inc NGS-based RNA-sequencing Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Thermo Fisher Scientific Inc
-
11.8.1 Thermo Fisher Scientific Inc Company Details
-
11.8.2 Thermo Fisher Scientific Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Thermo Fisher Scientific Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.8.4 Thermo Fisher Scientific Inc NGS-based RNA-sequencing Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Psomagen, Inc
-
11.9.1 Psomagen, Inc Company Details
-
11.9.2 Psomagen, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Psomagen, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.9.4 Psomagen, Inc NGS-based RNA-sequencing Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 PerkinElmer Inc
-
11.10.1 PerkinElmer Inc Company Details
-
11.10.2 PerkinElmer Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 PerkinElmer Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.10.4 PerkinElmer Inc NGS-based RNA-sequencing Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Takara Bio Inc
-
11.11.1 Takara Bio Inc Company Details
-
11.11.2 Takara Bio Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Takara Bio Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.11.4 Takara Bio Inc NGS-based RNA-sequencing Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Tecan Genomics, Inc
-
11.12.1 Tecan Genomics, Inc Company Details
-
11.12.2 Tecan Genomics, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Tecan Genomics, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.12.4 Tecan Genomics, Inc NGS-based RNA-sequencing Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Agilent Technologies, Inc
-
11.13.1 Agilent Technologies, Inc Company Details
-
11.13.2 Agilent Technologies, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Agilent Technologies, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
11.13.4 Agilent Technologies, Inc NGS-based RNA-sequencing Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global NGS-based RNA-sequencing Market Outlook by Types and Applications to 2028
-
12.1 Global NGS-based RNA-sequencing Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Sequencing by Synthesis Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Ion Semiconductor Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Single-molecule Real-time Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Nanopore Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global NGS-based RNA-sequencing Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Research & Academia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise NGS-based RNA-sequencing Market Analysis and Outlook to 2028
-
13.1 Global NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.2.2 Canada NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.2.3 Mexico NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.2 UK NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.3 Spain NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.4 Belgium NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.5 France NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.6 Italy NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.7 Denmark NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.8 Finland NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.9 Norway NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.10 Sweden NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.11 Poland NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.12 Russia NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.3.13 Turkey NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.2 Japan NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.3 India NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.4 South Korea NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.5 Pakistan NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.7 Indonesia NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.8 Thailand NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.9 Singapore NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.10 Malaysia NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.11 Philippines NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.4.12 Vietnam NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.2 Colombia NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.3 Chile NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.4 Argentina NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.5 Venezuela NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.6 Peru NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.5.8 Ecuador NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.6.2 Kuwait NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.6.3 Oman NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.6.4 Qatar NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.7.2 South Africa NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.7.3 Egypt NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.7.4 Algeria NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia NGS-based RNA-sequencing Consumption Forecast (2022-2028)
-
13.8.2 New Zealand NGS-based RNA-sequencing Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of NGS-based RNA-sequencing
-
Figure of NGS-based RNA-sequencing Picture
-
Table Global NGS-based RNA-sequencing Import by Region (Top 10 Countries) (2017-2028)
-
Table Global NGS-based RNA-sequencing Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Sequencing by Synthesis Consumption and Growth Rate (2017-2022)
-
Figure Global Ion Semiconductor Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global Single-molecule Real-time Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global Nanopore Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global Research & Academia Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals & Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Table North America NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure United States NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Canada NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Mexico NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table Europe NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure Germany NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure UK NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Spain NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Belgium NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure France NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Italy NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Denmark NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Finland NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Norway NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Sweden NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Poland NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Russia NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Turkey NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table APAC NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure China NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Japan NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure India NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure South Korea NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Pakistan NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Indonesia NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Thailand NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Singapore NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Malaysia NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Philippines NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Vietnam NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table South America NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure Brazil NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Colombia NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Chile NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Argentina NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Venezuela NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Peru NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Ecuador NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table GCC NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure Bahrain NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Kuwait NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Oman NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Qatar NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table Africa NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure Nigeria NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure South Africa NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Egypt NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure Algeria NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table Oceania NGS-based RNA-sequencing Consumption by Country (2017-2022)
-
Figure Australia NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Figure New Zealand NGS-based RNA-sequencing Consumption and Growth Rate (2017-2022)
-
Table Eurofins Genomics Germany GmbH Company Details
-
Table Eurofins Genomics Germany GmbH NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eurofins Genomics Germany GmbH NGS-based RNA-sequencing Main Business and Markets Served
-
Table Eurofins Genomics Germany GmbH NGS-based RNA-sequencing Product Portfolio
-
Table Oxford Nanopore Technologies Company Details
-
Table Oxford Nanopore Technologies NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford Nanopore Technologies NGS-based RNA-sequencing Main Business and Markets Served
-
Table Oxford Nanopore Technologies NGS-based RNA-sequencing Product Portfolio
-
Table QIAGEN Company Details
-
Table QIAGEN NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table QIAGEN NGS-based RNA-sequencing Main Business and Markets Served
-
Table QIAGEN NGS-based RNA-sequencing Product Portfolio
-
Table Hamilton Company Company Details
-
Table Hamilton Company NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hamilton Company NGS-based RNA-sequencing Main Business and Markets Served
-
Table Hamilton Company NGS-based RNA-sequencing Product Portfolio
-
Table BGI Company Details
-
Table BGI NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table BGI NGS-based RNA-sequencing Main Business and Markets Served
-
Table BGI NGS-based RNA-sequencing Product Portfolio
-
Table Zymo Research Company Details
-
Table Zymo Research NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zymo Research NGS-based RNA-sequencing Main Business and Markets Served
-
Table Zymo Research NGS-based RNA-sequencing Product Portfolio
-
Table Illumina, Inc Company Details
-
Table Illumina, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table Illumina, Inc NGS-based RNA-sequencing Product Portfolio
-
Table Thermo Fisher Scientific Inc Company Details
-
Table Thermo Fisher Scientific Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table Thermo Fisher Scientific Inc NGS-based RNA-sequencing Product Portfolio
-
Table Psomagen, Inc Company Details
-
Table Psomagen, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Psomagen, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table Psomagen, Inc NGS-based RNA-sequencing Product Portfolio
-
Table PerkinElmer Inc Company Details
-
Table PerkinElmer Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table PerkinElmer Inc NGS-based RNA-sequencing Product Portfolio
-
Table Takara Bio Inc Company Details
-
Table Takara Bio Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takara Bio Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table Takara Bio Inc NGS-based RNA-sequencing Product Portfolio
-
Table Tecan Genomics, Inc Company Details
-
Table Tecan Genomics, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tecan Genomics, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table Tecan Genomics, Inc NGS-based RNA-sequencing Product Portfolio
-
Table Agilent Technologies, Inc Company Details
-
Table Agilent Technologies, Inc NGS-based RNA-sequencing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies, Inc NGS-based RNA-sequencing Main Business and Markets Served
-
Table Agilent Technologies, Inc NGS-based RNA-sequencing Product Portfolio
-
Figure Global Sequencing by Synthesis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ion Semiconductor Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single-molecule Real-time Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nanopore Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research & Academia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals & Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Table North America NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure United States NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure Germany NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure France NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure China NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table South America NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure Brazil NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure Bahrain NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure Nigeria NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania NGS-based RNA-sequencing Consumption Forecast by Country (2022-2028)
-
Figure Australia NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand NGS-based RNA-sequencing Consumption Forecast and Growth Rate (2022-2028)
-
